Viewing Study NCT01955434


Ignite Creation Date: 2025-12-25 @ 2:34 AM
Ignite Modification Date: 2026-02-27 @ 5:19 PM
Study NCT ID: NCT01955434
Status: COMPLETED
Last Update Posted: 2019-09-10
First Post: 2013-09-27
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: SMAC Mimetic LCL161 Alone or With Cyclophosphamide in Treating Patients With Relapsed or Refractory Multiple Myeloma
Sponsor: Mayo Clinic
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Plasma Cell Myeloma View
None Refractory Plasma Cell Myeloma View
Keywords: